Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid... see more

Bullboard (TSXV:MIR)

View:
Post by goldyhawkon Feb 02, 2024 7:15am

MEDMIRA MYSTERIOUS THIRD HC SUBMISSION to

The update adds a third mystery HC ?? submission ??   from Medmira And it is not a complete submission apparently  the first two have been with HC for over  200 days  rather than ...more  
Post by goldyhawkon Feb 01, 2024 2:20pm

??.IS IT REVEAL TP SYPHILIS PLUS or what ??

Are they starting REVEAL TP PLUS  OR something  why submit REVEAL TP  and change it before it goes through an approval process ??!!!!!!!!
Comment by goldyhawkon Feb 01, 2024 11:13am

RE:New Press Release - CORRECTION BY SOURCE: Corporate Update on Clinical Evaluation of MedMira's Products

SEEMS TO BE SAYING  1—Medmira submitted a syphilis test  2–  someone (?) decided to improve on that test to extend its use (remember COVID PLUS ?) 3–. HINTS of extended talks needed ...more  
Comment by goldyhawkon Feb 01, 2024 10:53am

RE:?UPDATE ON JUNE 2023 mystery HC SUBMISSIONS??

Does not follow up on their previously announced intentions to keep shareholders informed and updated on WHEN SYPHILIS TEST IS SUBMITTED and updated on the two LINGERING mystery June 2023   ...more  
Post by goldyhawkon Jan 28, 2024 1:55pm

PRE AGM note —SAME AS LAST YEAR?

I have no hope for MEDMIRA  and don’t want any repetitive updates  I have great expectations from all the good vibrations they’ve been sending out over the past year and more 
Comment by goldyhawkon Jan 25, 2024 11:34am

RE:MEDMIRA’S UPCOMING CLIA WAIVER

Of course  Medmira will receive a a waiver not a moderate or high complexity certification if any  i wonder when they started their application for waiver as they refer to it as an ongoing ...more  
Post by goldyhawkon Jan 25, 2024 9:42am

MEDMIRA’S UPCOMING CLIA WAIVER

In its dec 29 2023 news release  Medmira mentions its “ upcoming CLIA waiver” no timeline was mentioned -Nor was the expected  waiver class 
Post by goldyhawkon Jan 24, 2024 1:41pm

Seems a lot of Medmira’s future

???? Is not about just getting an approval but more importantly a waiver ????? after an approval how many years does a waiver take???
Comment by goldyhawkon Jan 17, 2024 12:51pm

RE:75 day standard grows into app 200 days

According  to dec md&a company has talked to hc directorate and is confident it can meet all hc requirements An update is promised this month  — usually updates are just annoying ...more  
Post by goldyhawkon Jan 17, 2024 9:45am

75 day standard grows into app 200 days

For Medmira’s two secret June 2023  submissions  ? what’s wrong ?  NOTHING ????
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities